prompt,answer
"[Company Introduction]:

Amgen Inc is a leading entity in the Biotechnology sector. Incorporated and publicly traded since 1983-06-17, the company has established its reputation as one of the key players in the market. As of today, Amgen Inc has a market capitalization of 180145.00 in USD, with 537.33 shares outstanding.

Amgen Inc operates primarily in the US, trading under the ticker AMGN on the NASDAQ NMS - GLOBAL MARKET. As a dominant force in the Biotechnology space, the company continues to innovate and drive progress within the industry.

From 2023-01-08 to 2023-01-15, AMGN's stock price decreased from 260.24 to 256.96. News during this period are listed below:

No relative news reported.
[Basic Financials]:

No basic financial reported.

Based on all the information before 2023-01-15, let's first analyze the positive developments and potential concerns for AMGN. Come up with 2-4 most important factors respectively and keep them concise. Most factors should be inferred from company related news. Then let's assume your prediction for next week (2023-01-15 to 2023-01-22) is down by 3-4%. Provide a summary analysis to support your prediction. The prediction result need to be inferred from your analysis at the end, and thus not appearing as a foundational factor of your analysis.","[Positive Developments]:
1. Amgen Inc is a leading entity in the Biotech sector, which means it has the potential to bounce back from any unfortunate dips in stock prices.
2. Despite a slight decrease this past week, compared to historical data, the stock price still remains relatively stable.

[Potential Concerns]:
1. The stock price decreased from 260.24 to 256.96 last week.
2. A lack of new developments or news suggests that the company might be stagnating, which is not ideal for investors looking for growth or dynamic change.
3. Also, absence of current basic financials for the company could discourage potential investors due to lack of transparency and inability to judge the company's current performance.

[Prediction & Analysis]:

Amgen Inc's stock price recently experienced a slight dip. While it's normal for prices to fluctuate in the stock market, the lack of news about recent developments is concerning. Without this, it's quite difficult to foresee any stimuli that might influence the stock's price positively in the next week. Also, the lack of basic financials makes it troublesome to detect any improvements or disturbances in the company's profitability, which can often serve as indications for future stock price fluctuations.

Given this, it's safer to predict that the stock price may further drop by 3-4% next week due to the lack of any foreseeable positive catalysts. An absence of directional indicators paints a picture of uncertainty for Amgen, which traditionally results in a reticence among investors and causes a slight depress in stock prices.

However, given the leading status of Amgen in its sector, it is poised for a rebound once any significant news or positive developments are announced in the future. As we move into the next week, one should keep a close eye on any possible new information about the company to adjust investment strategies accordingly."
"[Company Introduction]:

Amgen Inc is a leading entity in the Biotechnology sector. Incorporated and publicly traded since 1983-06-17, the company has established its reputation as one of the key players in the market. As of today, Amgen Inc has a market capitalization of 180145.00 in USD, with 537.33 shares outstanding.

Amgen Inc operates primarily in the US, trading under the ticker AMGN on the NASDAQ NMS - GLOBAL MARKET. As a dominant force in the Biotechnology space, the company continues to innovate and drive progress within the industry.

From 2023-01-08 to 2023-01-15, AMGN's stock price decreased from 260.24 to 256.96. News during this period are listed below:

No relative news reported.
From 2023-01-15 to 2023-01-22, AMGN's stock price decreased from 256.96 to 248.93. News during this period are listed below:

No relative news reported.
[Basic Financials]:

No basic financial reported.

Based on all the information before 2023-01-22, let's first analyze the positive developments and potential concerns for AMGN. Come up with 2-4 most important factors respectively and keep them concise. Most factors should be inferred from company related news. Then let's assume your prediction for next week (2023-01-22 to 2023-01-29) is down by 3-4%. Provide a summary analysis to support your prediction. The prediction result need to be inferred from your analysis at the end, and thus not appearing as a foundational factor of your analysis.","[Positive Developments]:
1. The absence of any negative news reports could indicate operational stability within the company.
2. Amgen Inc continues to maintain its role as a leading entity within the biotech sector, showing their durability and resilience within the market.

[Potential Concerns]:
1. The continuous decline in the stock price over the last two weeks might indicate a trend of weak investor confidence.
2. The lack of positive news reports may imply stagnant growth or lack of significant progress in the company.
3. No basic financials reported - these are key to evaluate the health of the company, and the lack of transparency may concern investors.

[Prediction & Analysis]:

Given the fact that the stock price of Amgen has been on a descent for two consecutive weeks and there is no significant positive news to reverse the negative sentiment, it's plausible to predict that this trend may continue. The absence of basic financials also creates uncertainty around the company's current performance, potentially increasing investor conservatism. Thus, I predict a likely downward movement of around 3-4% in the stock price for the following week. However, as a leader in the biotech industry, any significant news or announcements could significantly impact this prediction. Investors should monitor the company's activities and its market closely."
"[Company Introduction]:

Amgen Inc is a leading entity in the Biotechnology sector. Incorporated and publicly traded since 1983-06-17, the company has established its reputation as one of the key players in the market. As of today, Amgen Inc has a market capitalization of 180145.00 in USD, with 537.33 shares outstanding.

Amgen Inc operates primarily in the US, trading under the ticker AMGN on the NASDAQ NMS - GLOBAL MARKET. As a dominant force in the Biotechnology space, the company continues to innovate and drive progress within the industry.

From 2023-01-08 to 2023-01-15, AMGN's stock price decreased from 260.24 to 256.96. News during this period are listed below:

No relative news reported.
From 2023-01-15 to 2023-01-22, AMGN's stock price decreased from 256.96 to 248.93. News during this period are listed below:

No relative news reported.
From 2023-01-22 to 2023-01-29, AMGN's stock price decreased from 248.93 to 239.87. News during this period are listed below:

No relative news reported.
[Basic Financials]:

No basic financial reported.

Based on all the information before 2023-01-29, let's first analyze the positive developments and potential concerns for AMGN. Come up with 2-4 most important factors respectively and keep them concise. Most factors should be inferred from company related news. Then let's assume your prediction for next week (2023-01-29 to 2023-02-05) is down by 3-4%. Provide a summary analysis to support your prediction. The prediction result need to be inferred from your analysis at the end, and thus not appearing as a foundational factor of your analysis.","[Positive Developments]:
1. Amgen has a strong history of innovation and a robust product line, contributing to its overall market position.
2. The company has a large market capitalization, demonstrating strength and stability in the market.

[Potential Concerns]:
1. A steady decrease in the stock price over the past weeks without any observable news, indicating potential undisclosed issues or market disfavor.
2. Due to the lack of recent financials, there's uncertainty about the company's current state of profitability and operation.

[Prediction & Analysis]:
Over the past weeks, despite no significant publicly disclosed events, there has been a consistent downward trend in Amgen's stock price. This decline could be caused by various factors, such as general market sentiment, internal company dynamics, undisclosed issues, or industry trends. Although Amgen has a history of innovation and holds a significant market position, the lack of transparency into its recent operations and financials adds to the uncertainty for investors. Considering the aforementioned factors, it can be predicted that the stock price might continue to trend downwards in the upcoming week by approximately 3-4%. Investors should closely monitor any forthcoming announcements from the company or shifts in the market dynamics. The detailed earnings report, when available, will provide more insights into the financial health and future prospects of the company."
"[Company Introduction]:

Amgen Inc is a leading entity in the Biotechnology sector. Incorporated and publicly traded since 1983-06-17, the company has established its reputation as one of the key players in the market. As of today, Amgen Inc has a market capitalization of 180145.00 in USD, with 537.33 shares outstanding.

Amgen Inc operates primarily in the US, trading under the ticker AMGN on the NASDAQ NMS - GLOBAL MARKET. As a dominant force in the Biotechnology space, the company continues to innovate and drive progress within the industry.

From 2023-01-22 to 2023-01-29, AMGN's stock price decreased from 248.93 to 239.87. News during this period are listed below:

No relative news reported.
From 2023-01-29 to 2023-02-05, AMGN's stock price decreased from 239.87 to 231.85. News during this period are listed below:

No relative news reported.
[Basic Financials]:

No basic financial reported.

Based on all the information before 2023-02-05, let's first analyze the positive developments and potential concerns for AMGN. Come up with 2-4 most important factors respectively and keep them concise. Most factors should be inferred from company related news. Then let's assume your prediction for next week (2023-02-05 to 2023-02-12) is down by 1-2%. Provide a summary analysis to support your prediction. The prediction result need to be inferred from your analysis at the end, and thus not appearing as a foundational factor of your analysis.","[Positive Developments]:
1. Amgen Inc is a leading entity and innovator in the Biotechnology sector with a strong market capitalization. 
2. The company has a stable presence, primarily operating in the US market. 

[Potential Concerns]:
1. The stock price for Amgen Inc has consistently decreased over the past weeks.
2. The absence of recent news or basic financial reports from the company can create uncertainty among investors.
3. The negative trend and lack of new developments could signal low momentum for the company.

[Prediction & Analysis]:
Given the currently observed decreasing trend in AMGN's stock price, the lack of fresh news about the company's operations, and the absence of recent financial reports, we foresee the stock price to continue trending downward in the upcoming week. This declining trend coupled with the absence of material news may imply reduced investor confidence and interest, which can continue to weigh down the stock, resulting in a predicted 1-2% decrease in stock price for the next week. However, it's crucial to monitor for any new developments that could potentially affect the outlook of the company."
"[Company Introduction]:

Amgen Inc is a leading entity in the Biotechnology sector. Incorporated and publicly traded since 1983-06-17, the company has established its reputation as one of the key players in the market. As of today, Amgen Inc has a market capitalization of 180145.00 in USD, with 537.33 shares outstanding.

Amgen Inc operates primarily in the US, trading under the ticker AMGN on the NASDAQ NMS - GLOBAL MARKET. As a dominant force in the Biotechnology space, the company continues to innovate and drive progress within the industry.

From 2023-02-05 to 2023-02-12, AMGN's stock price decreased from 231.85 to 229.32. News during this period are listed below:

No relative news reported.
[Basic Financials]:

No basic financial reported.

Based on all the information before 2023-02-12, let's first analyze the positive developments and potential concerns for AMGN. Come up with 2-4 most important factors respectively and keep them concise. Most factors should be inferred from company related news. Then let's assume your prediction for next week (2023-02-12 to 2023-02-19) is up by 0-1%. Provide a summary analysis to support your prediction. The prediction result need to be inferred from your analysis at the end, and thus not appearing as a foundational factor of your analysis.","[Positive Developments]:
1. Despite the minor decrease in stock price, Amgen's overall performance in the biotechnology sector remains robust, suggesting investor confidence.
2. The absence of negative news could indicate stability in the company's operations and suggest that it has effectively managed foreseeable risks.

[Potential Concerns]:
1. Lack of news or updates may potentially indicate a lack of growth catalysts, which could be a concern for investors seeking aggressive growth.
2. The decrease in stock price may arouse concern among shareholders regarding its future performance.

[Prediction & Analysis]:

Given the absence of noteworthy news from Amgen, the company's stable positioning in a highly innovative sector, such as Biotechnology, favors its credibility and investor confidence in the stock, which suggests that the slight price decrease is a regular market fluctuation rather than an issue within the company. However, the lack of significant developments does put the company at a potential disadvantage, lacking growth catalysts that could inspire investor interest and propel substantial growth. 

Though there may be concerns regarding the slight decrease in the company's share price, without any substantiated negative news, this change could be attributable to broader market trends rather than company-specific factors. In the upcoming week, the stock price could potentially see a minor rise of 0-1%, reflecting the stable background of the company in its competitive industry. 

While future growth may be reliant on incoming news regarding business updates or advancements in their pipeline, for the week ahead, absent of any major negative impacts, it is predicted that Amgen's stock will remain relatively steady with a minor rise. This prediction is based on the understanding of the company's stand in the industry and the lack of any adverse news affecting its operations."
"[Company Introduction]:

Amgen Inc is a leading entity in the Biotechnology sector. Incorporated and publicly traded since 1983-06-17, the company has established its reputation as one of the key players in the market. As of today, Amgen Inc has a market capitalization of 180145.00 in USD, with 537.33 shares outstanding.

Amgen Inc operates primarily in the US, trading under the ticker AMGN on the NASDAQ NMS - GLOBAL MARKET. As a dominant force in the Biotechnology space, the company continues to innovate and drive progress within the industry.

From 2023-02-12 to 2023-02-19, AMGN's stock price increased from 229.32 to 229.46. News during this period are listed below:

No relative news reported.
[Basic Financials]:

No basic financial reported.

Based on all the information before 2023-02-19, let's first analyze the positive developments and potential concerns for AMGN. Come up with 2-4 most important factors respectively and keep them concise. Most factors should be inferred from company related news. Then let's assume your prediction for next week (2023-02-19 to 2023-02-26) is down by 2-3%. Provide a summary analysis to support your prediction. The prediction result need to be inferred from your analysis at the end, and thus not appearing as a foundational factor of your analysis.","[Positive Developments]:
1. Amgen Inc's stock price has seen a slight increase over the past week, which may signal positive investor sentiment.
2. As a dominant force in the Biotechnology space, Amgen Inc's continued innovation and progression within the industry represent a potential long-term upside.

[Potential Concerns]:
1. The lack of recent notable news or financial reports may create uncertainty among investors, potentially leading to decreased stock activity or downward price movement.
2. Due to the dynamics of the Biotechnology sector, the absence of recent news may imply there are no new product releases or breakthroughs, which could negatively impact stock price.

[Prediction & Analysis]:
Given the lack of significant recent developments and the absence of news or financial updates, investors could interpret this as a period of stagnation for Amgen Inc. In light of the highly competitive and innovation-driven nature of the biotechnology industry, the lack of recent progress might give rise to investor concerns and contribute to a drop in the stock price. 

Therefore, it's predicted that Amgen Inc's stock price may potentially decrease by 2-3% in the upcoming week, considering the current lack of momentum and potential investor hesitancy due to the dearth of recent company news or financials.
Please note that this prediction is based on existing conditions and stock market fluctuations are notoriously difficult to predict with absolute certainty."
"[Company Introduction]:

Amgen Inc is a leading entity in the Biotechnology sector. Incorporated and publicly traded since 1983-06-17, the company has established its reputation as one of the key players in the market. As of today, Amgen Inc has a market capitalization of 180145.00 in USD, with 537.33 shares outstanding.

Amgen Inc operates primarily in the US, trading under the ticker AMGN on the NASDAQ NMS - GLOBAL MARKET. As a dominant force in the Biotechnology space, the company continues to innovate and drive progress within the industry.

From 2023-01-29 to 2023-02-05, AMGN's stock price decreased from 239.87 to 231.85. News during this period are listed below:

No relative news reported.
From 2023-02-05 to 2023-02-12, AMGN's stock price decreased from 231.85 to 229.32. News during this period are listed below:

No relative news reported.
From 2023-02-12 to 2023-02-19, AMGN's stock price increased from 229.32 to 229.46. News during this period are listed below:

No relative news reported.
From 2023-02-19 to 2023-02-26, AMGN's stock price decreased from 229.46 to 222.91. News during this period are listed below:

No relative news reported.
[Basic Financials]:

No basic financial reported.

Based on all the information before 2023-02-26, let's first analyze the positive developments and potential concerns for AMGN. Come up with 2-4 most important factors respectively and keep them concise. Most factors should be inferred from company related news. Then let's assume your prediction for next week (2023-02-26 to 2023-03-05) is up by 0-1%. Provide a summary analysis to support your prediction. The prediction result need to be inferred from your analysis at the end, and thus not appearing as a foundational factor of your analysis.","[Positive Developments]:
1. The company maintains stability without any apparent incidents that could detrimentally impact its stock. 
2. In the absence of adverse headlines, investors may be reassured by the company's existing leadership within the Biotechnology sector.

[Potential Concerns]:
1. The stock has seen continuous decline in the past few weeks from 239.87 (2023-01-29) to 222.91 (2023-02-26), indicating a down trend.
2. In the absence of any positive headlines or favorable news, this may not attract investor sentiment and may potentially hinder the company's stock price growth.

[Prediction & Analysis]:

Despite concerns related to the downward trend of late, AMGN's stock price is predicted to go up slightly by 0-1% in the next week. Though there have been no notable developments or news recently, the lack of any negative news puts the company in a stable position. As a market leader, this relative stability could make Amgen Inc's stock appealing to conservative investors, or those looking to hedge more volatile investments.

Furthermore, fluctuations in stock prices in the absence of news are common in the market. It may be that the stock has been over-sold due to general market trends or dynamics, which would make a slight recovery likely in the short run, providing a ray of optimism. However, the company should strive to generate positive headwinds through investor updates or operational improvements to ensure a positive sentiment is maintained among its investors. 

The overall lack of substantial news implies that the prediction does have a moderate level of uncertainty, and developments in the coming weeks should be closely monitored. It is always recommended that investors maintain a diversified portfolio to mitigate potential risks."
"[Company Introduction]:

Amgen Inc is a leading entity in the Biotechnology sector. Incorporated and publicly traded since 1983-06-17, the company has established its reputation as one of the key players in the market. As of today, Amgen Inc has a market capitalization of 180145.00 in USD, with 537.33 shares outstanding.

Amgen Inc operates primarily in the US, trading under the ticker AMGN on the NASDAQ NMS - GLOBAL MARKET. As a dominant force in the Biotechnology space, the company continues to innovate and drive progress within the industry.

From 2023-02-12 to 2023-02-19, AMGN's stock price increased from 229.32 to 229.46. News during this period are listed below:

No relative news reported.
From 2023-02-19 to 2023-02-26, AMGN's stock price decreased from 229.46 to 222.91. News during this period are listed below:

No relative news reported.
From 2023-02-26 to 2023-03-05, AMGN's stock price increased from 222.91 to 224.01. News during this period are listed below:

No relative news reported.
[Basic Financials]:

No basic financial reported.

Based on all the information before 2023-03-05, let's first analyze the positive developments and potential concerns for AMGN. Come up with 2-4 most important factors respectively and keep them concise. Most factors should be inferred from company related news. Then let's assume your prediction for next week (2023-03-05 to 2023-03-12) is down by 2-3%. Provide a summary analysis to support your prediction. The prediction result need to be inferred from your analysis at the end, and thus not appearing as a foundational factor of your analysis.","[Positive Developments]:
1. The Biotechnology sector, where AMGN operates, is a rapidly growing industry with promising innovation breakthroughs that may add value to the company.
2. The company has shown its ability to maintain its stock price relatively stable during periods without any news, which suggests that its financials and operations are strong and stable.

[Potential Concerns]:
1. A week-to-week analysis of AMGN stock shows a decreasing trend where prices have moved from $229.46 to $224.01, suggesting potentially bearish sentiment among investors.
2. The lack of recent relevant news about the company might imply a standstill in strategic developments or successful projects, which may not attract potential investors.

[Prediction & Analysis]:

Given the recent decreasing trend in company stock prices, combined with the absence of relevant news and developments, it seems reasonable to infer a potential downward adjustment in the upcoming week. The lack of strategic news may keep investors' sentiment low, resulting in a further drop in the stock price. 

However, due to the company's past stability and its prominence in the Biotechnology sector, the drop is not predicted to be severe. Overall, we can expect a decrease of approximately 2-3% in the AMGN stock price for the week of 2023-03-05 to 2023-03-12. Investors and stakeholders should keep a close eye on industry developments and AMGN's future news to assess further potential impacts on the company's stock performance."
"[Company Introduction]:

Amgen Inc is a leading entity in the Biotechnology sector. Incorporated and publicly traded since 1983-06-17, the company has established its reputation as one of the key players in the market. As of today, Amgen Inc has a market capitalization of 180145.00 in USD, with 537.33 shares outstanding.

Amgen Inc operates primarily in the US, trading under the ticker AMGN on the NASDAQ NMS - GLOBAL MARKET. As a dominant force in the Biotechnology space, the company continues to innovate and drive progress within the industry.

From 2023-02-12 to 2023-02-19, AMGN's stock price increased from 229.32 to 229.46. News during this period are listed below:

No relative news reported.
From 2023-02-19 to 2023-02-26, AMGN's stock price decreased from 229.46 to 222.91. News during this period are listed below:

No relative news reported.
From 2023-02-26 to 2023-03-05, AMGN's stock price increased from 222.91 to 224.01. News during this period are listed below:

No relative news reported.
From 2023-03-05 to 2023-03-12, AMGN's stock price decreased from 224.01 to 217.39. News during this period are listed below:

No relative news reported.
[Basic Financials]:

No basic financial reported.

Based on all the information before 2023-03-12, let's first analyze the positive developments and potential concerns for AMGN. Come up with 2-4 most important factors respectively and keep them concise. Most factors should be inferred from company related news. Then let's assume your prediction for next week (2023-03-12 to 2023-03-19) is up by 0-1%. Provide a summary analysis to support your prediction. The prediction result need to be inferred from your analysis at the end, and thus not appearing as a foundational factor of your analysis.","[Positive Developments]:
1. Despite market fluctuations, the overall performance of Amgen Inc. remains relatively stable with minor increases and decreases in stock price, indicating a potential resilience to market downtrends.
2. Amgen operates in the biotechnology sector which is considered a high growth area due to the increased demand for healthcare and pharmaceutical solutions, especially in the current global scenario.
   
[Potential Concerns]:
1. The lack of recent company-specific news or announcements may indicate a stagnant growth period for the company which could be a concern for investors looking for regular updates.
2. The company's stock price has seen a slight decline in its value flipping between decreases and increases, which may indicate potential volatility or inconsistency in its performance.

[Prediction & Analysis]:
The stock of Amgen Inc. seems to be in a phase where it's showing minor fluctuations, hovering around the same value for the past month. The lack of any specific news about the company in recent weeks may be causing investor sentiment to remain neutral, contributing to the relatively flat movement in the stock price. However, considering the company operates in the high-growth biotechnology sector, the resilience it has shown despite the variations in the market can be considered a positive sign. Though there has been a slight downward trend, a mature biotech company like Amgen may possibly bounce back in the short term. Hence, the stock price is predicted to see a small uptick and likely to increase by 0-1% in the following week, reflecting the anticipation of any potential positive news or developments from the company."
"[Company Introduction]:

Amgen Inc is a leading entity in the Biotechnology sector. Incorporated and publicly traded since 1983-06-17, the company has established its reputation as one of the key players in the market. As of today, Amgen Inc has a market capitalization of 180145.00 in USD, with 537.33 shares outstanding.

Amgen Inc operates primarily in the US, trading under the ticker AMGN on the NASDAQ NMS - GLOBAL MARKET. As a dominant force in the Biotechnology space, the company continues to innovate and drive progress within the industry.

From 2023-02-19 to 2023-02-26, AMGN's stock price decreased from 229.46 to 222.91. News during this period are listed below:

No relative news reported.
From 2023-02-26 to 2023-03-05, AMGN's stock price increased from 222.91 to 224.01. News during this period are listed below:

No relative news reported.
From 2023-03-05 to 2023-03-12, AMGN's stock price decreased from 224.01 to 217.39. News during this period are listed below:

No relative news reported.
From 2023-03-12 to 2023-03-19, AMGN's stock price increased from 217.39 to 219.22. News during this period are listed below:

No relative news reported.
[Basic Financials]:

No basic financial reported.

Based on all the information before 2023-03-19, let's first analyze the positive developments and potential concerns for AMGN. Come up with 2-4 most important factors respectively and keep them concise. Most factors should be inferred from company related news. Then let's assume your prediction for next week (2023-03-19 to 2023-03-26) is up by 3-4%. Provide a summary analysis to support your prediction. The prediction result need to be inferred from your analysis at the end, and thus not appearing as a foundational factor of your analysis.","[Positive Developments]:
1. Despite fluctuations, there is a slight overall increase in AMGN's stock price over the analyzed period, indicating relatively stable market confidence in the company's prospects.
2. The biotechnology sector in general is seeing a surge of interest due to its key role in addressing major global health crises, which could bode well for companies like Amgen.

[Potential Concerns]:
1. The lack of news regarding Amgen's operations might indicate a potential stagnation or lack of major advancements in their pipeline, which could impact the investors' outlook. 
2. The company's stock price has shown some instability in the recent weeks, which might be a source of concern for investors looking for steady growth and low risk.

[Prediction & Analysis]:

Based on the overall slight increase in AMGN's stock price, and in absence of any negative news about the company or the sector, we can predict a potential rise in stock price. The Biotechnology sector is continuously growing, and new developments are emerging. While the lack of news from Amgen might raise some concerns about their pipeline, it also opens up space for potential positive surprises.

Given the information provided, it is reasonable to predict an increase by approximately 3-4% for the upcoming week. Nevertheless, investors should keep a close eye for any news or indicators that might signal upcoming changes."
"[Company Introduction]:

Amgen Inc is a leading entity in the Biotechnology sector. Incorporated and publicly traded since 1983-06-17, the company has established its reputation as one of the key players in the market. As of today, Amgen Inc has a market capitalization of 180145.00 in USD, with 537.33 shares outstanding.

Amgen Inc operates primarily in the US, trading under the ticker AMGN on the NASDAQ NMS - GLOBAL MARKET. As a dominant force in the Biotechnology space, the company continues to innovate and drive progress within the industry.

From 2023-02-26 to 2023-03-05, AMGN's stock price increased from 222.91 to 224.01. News during this period are listed below:

No relative news reported.
From 2023-03-05 to 2023-03-12, AMGN's stock price decreased from 224.01 to 217.39. News during this period are listed below:

No relative news reported.
From 2023-03-12 to 2023-03-19, AMGN's stock price increased from 217.39 to 219.22. News during this period are listed below:

No relative news reported.
From 2023-03-19 to 2023-03-26, AMGN's stock price increased from 219.22 to 227.08. News during this period are listed below:

No relative news reported.
Some recent basic financials of AMGN, reported at 2023-03-31, are presented below:

[Basic Financials]:

assetTurnoverTTM: 0.3784
bookValue: 5348
cashRatio: 2.2201899402040097
currentRatio: 3.1448
ebitPerShare: 3.7807
eps: 5.2807
ev: 159129.5
fcfMargin: 0.1179
fcfPerShareTTM: 14.103
grossMargin: 0.7245
inventoryTurnoverTTM: 1.3855
longtermDebtTotalAsset: 0.6849
longtermDebtTotalCapital: 0.9077
longtermDebtTotalEquity: 11.3614
netDebtToTotalCapital: 0.4487
netDebtToTotalEquity: 5.6161
netMargin: 0.4654
operatingMargin: 0.3332
payoutRatioTTM: 0.5372
pb: 24.1388
peTTM: 16.306
pfcfTTM: 17.1417
pretaxMargin: 0.5638
psTTM: 4.9292
quickRatio: 2.7923
receivablesTurnoverTTM: 4.8442
roaTTM: 0.1144
roeTTM: 2.0999
roicTTM: 0.1659
rotcTTM: 0.1924
salesPerShare: 11.3476
sgaToSale: 0.2755
totalDebtToEquity: 11.5174
totalDebtToTotalAsset: 0.6943
totalDebtToTotalCapital: 0.9201
totalRatio: 1.0641

Based on all the information before 2023-03-26, let's first analyze the positive developments and potential concerns for AMGN. Come up with 2-4 most important factors respectively and keep them concise. Most factors should be inferred from company related news. Then let's assume your prediction for next week (2023-03-26 to 2023-04-02) is up by 1-2%. Provide a summary analysis to support your prediction. The prediction result need to be inferred from your analysis at the end, and thus not appearing as a foundational factor of your analysis.","[Positive Developments]:
1. Overall, the AMGN stock price has been in an upward trend.
2. The company has a healthy gross margin (0.7245), indicating profitable operations.
3. AMGN's free cash flow per share (14.103) suggests strong liquidity.

[Potential Concerns]:
1. The company has a high debt to equity ratio (11.5174) showing substantial reliance on debt for operations.
2. The lack of notable news for AMGN recently could mean little catalyst for further price jumps in the short term.

[Prediction & Analysis]:

Over the past few weeks, Amgen's stock price has experienced an upward trend, suggesting investor optimism for the company's future performance. Its high gross margin and free cash flow per share indicate operational profitability and liquidity. These factors may lead to an enhancement in investor sentiment, driving further stock price upturns.

Despite some concerns, such as the high debt-to-equity ratio that suggests considerable reliance on borrowed funds for its operations, these do not undermine the general positive outlook for Amgn's stock. However, in the absence of reported news directly related to AMGN, determing the stock's short-term performance may prove challenging. Upcoming news and announcements may serve as driving factors for further price movements.

Given these developments and perceptions, my analysis suggests a bullish trend for Amgn's stock in the upcoming week of March 26th to April 2nd, potentially seeing a modest rise of 1-2%. The positive trend, gross margin, and cash flow per share seem to outweigh potential concerns. However, investors should monitor the company's news and financial statement release for potential impacts on the stock's price."
"[Company Introduction]:

Amgen Inc is a leading entity in the Biotechnology sector. Incorporated and publicly traded since 1983-06-17, the company has established its reputation as one of the key players in the market. As of today, Amgen Inc has a market capitalization of 180145.00 in USD, with 537.33 shares outstanding.

Amgen Inc operates primarily in the US, trading under the ticker AMGN on the NASDAQ NMS - GLOBAL MARKET. As a dominant force in the Biotechnology space, the company continues to innovate and drive progress within the industry.

From 2023-03-26 to 2023-04-02, AMGN's stock price increased from 227.08 to 230.63. News during this period are listed below:

No relative news reported.
Some recent basic financials of AMGN, reported at 2023-03-31, are presented below:

[Basic Financials]:

assetTurnoverTTM: 0.3784
bookValue: 5348
cashRatio: 2.2201899402040097
currentRatio: 3.1448
ebitPerShare: 3.7807
eps: 5.2807
ev: 159129.5
fcfMargin: 0.1179
fcfPerShareTTM: 14.103
grossMargin: 0.7245
inventoryTurnoverTTM: 1.3855
longtermDebtTotalAsset: 0.6849
longtermDebtTotalCapital: 0.9077
longtermDebtTotalEquity: 11.3614
netDebtToTotalCapital: 0.4487
netDebtToTotalEquity: 5.6161
netMargin: 0.4654
operatingMargin: 0.3332
payoutRatioTTM: 0.5372
pb: 24.1388
peTTM: 16.306
pfcfTTM: 17.1417
pretaxMargin: 0.5638
psTTM: 4.9292
quickRatio: 2.7923
receivablesTurnoverTTM: 4.8442
roaTTM: 0.1144
roeTTM: 2.0999
roicTTM: 0.1659
rotcTTM: 0.1924
salesPerShare: 11.3476
sgaToSale: 0.2755
totalDebtToEquity: 11.5174
totalDebtToTotalAsset: 0.6943
totalDebtToTotalCapital: 0.9201
totalRatio: 1.0641

Based on all the information before 2023-04-02, let's first analyze the positive developments and potential concerns for AMGN. Come up with 2-4 most important factors respectively and keep them concise. Most factors should be inferred from company related news. Then let's assume your prediction for next week (2023-04-02 to 2023-04-09) is up by 4-5%. Provide a summary analysis to support your prediction. The prediction result need to be inferred from your analysis at the end, and thus not appearing as a foundational factor of your analysis.","[Positive Developments]:
1. Amgen Inc's earnings per share (EPS) is impressive, indicating they have been profitable.
2. The company has a high rate of cash reserves, indicated by its high cash ratio and quick ratio, which suggests Amgen is well prepared for potential future downfall.
3. Its gross margin and operating margin suggest it's well-managed from an operational perspective.
   
[Potential Concerns]:
1. The long term debt to total asset ratio shows that a significant portion of the company's assets are financed by long-term debt which might weigh on company's balance sheet.
2. High receivables turnover indicates that the company may have trouble collecting payment from its customers.
3. Despite having high cash reserves, the company's payout ratioTTM is relatively high which might be a concern for future investors looking for dividends payment.

[Prediction & Analysis]:

Considering the above developments and concerns, it is prudent to suggest that the stock price of Amgen Inc. is likely to go up by around 4-5% in the coming week. The company's impressive EPS figures, above average cash reserves, and efficient operational management are strong indicators of its robust financial health and profitability potential. These factors should provide confidence to investors and stimulate a positive trend in stock price. 

However, it must also be noted that the company has a high long-term debt to asset ratio and a high receivables turnover which could hinder the aggressive growth as its resources might be constrained by debt payment and could experience difficulties in finances from collections. 

Given these attributes, the company's potential for continued profitability outweighs the concerns of a higher debt load and collection issues, thus the prediction for a rise in stock price for the upcoming week. The company's strength in its financial ratios indicates that it has the ability to take on these challenges. The increase in stock price prediction is also supported by the track record of the company's stock price being reflective of its intrinsic value, coupled with its historical resilience in market downturns."
"[Company Introduction]:

Amgen Inc is a leading entity in the Biotechnology sector. Incorporated and publicly traded since 1983-06-17, the company has established its reputation as one of the key players in the market. As of today, Amgen Inc has a market capitalization of 180145.00 in USD, with 537.33 shares outstanding.

Amgen Inc operates primarily in the US, trading under the ticker AMGN on the NASDAQ NMS - GLOBAL MARKET. As a dominant force in the Biotechnology space, the company continues to innovate and drive progress within the industry.

From 2023-03-12 to 2023-03-19, AMGN's stock price increased from 217.39 to 219.22. News during this period are listed below:

No relative news reported.
From 2023-03-19 to 2023-03-26, AMGN's stock price increased from 219.22 to 227.08. News during this period are listed below:

No relative news reported.
From 2023-03-26 to 2023-04-02, AMGN's stock price increased from 227.08 to 230.63. News during this period are listed below:

No relative news reported.
From 2023-04-02 to 2023-04-09, AMGN's stock price increased from 230.63 to 241.67. News during this period are listed below:

No relative news reported.
Some recent basic financials of AMGN, reported at 2023-03-31, are presented below:

[Basic Financials]:

assetTurnoverTTM: 0.3784
bookValue: 5348
cashRatio: 2.2201899402040097
currentRatio: 3.1448
ebitPerShare: 3.7807
eps: 5.2807
ev: 159129.5
fcfMargin: 0.1179
fcfPerShareTTM: 14.103
grossMargin: 0.7245
inventoryTurnoverTTM: 1.3855
longtermDebtTotalAsset: 0.6849
longtermDebtTotalCapital: 0.9077
longtermDebtTotalEquity: 11.3614
netDebtToTotalCapital: 0.4487
netDebtToTotalEquity: 5.6161
netMargin: 0.4654
operatingMargin: 0.3332
payoutRatioTTM: 0.5372
pb: 24.1388
peTTM: 16.306
pfcfTTM: 17.1417
pretaxMargin: 0.5638
psTTM: 4.9292
quickRatio: 2.7923
receivablesTurnoverTTM: 4.8442
roaTTM: 0.1144
roeTTM: 2.0999
roicTTM: 0.1659
rotcTTM: 0.1924
salesPerShare: 11.3476
sgaToSale: 0.2755
totalDebtToEquity: 11.5174
totalDebtToTotalAsset: 0.6943
totalDebtToTotalCapital: 0.9201
totalRatio: 1.0641

Based on all the information before 2023-04-09, let's first analyze the positive developments and potential concerns for AMGN. Come up with 2-4 most important factors respectively and keep them concise. Most factors should be inferred from company related news. Then let's assume your prediction for next week (2023-04-09 to 2023-04-16) is down by 1-2%. Provide a summary analysis to support your prediction. The prediction result need to be inferred from your analysis at the end, and thus not appearing as a foundational factor of your analysis.","[Positive Developments]:
1. The stock price of Amgen Inc has shown a consecutive increase over the past four weeks, implying positive market sentiment.
2. The company has a healthy earnings per share (EPS) of 5.2807, which might appeal to income-focused investors.
3. The operating margin is 0.3332, indicating the company can convert a sizable portion of its revenue into profit.

[Potential Concerns]:
1. The company's total debt to equity ratio is high (11.5174), indicating that the company has been aggressively financing its growth with debt. This can be risky if the interest expenses start to outweigh operating profits.
2. The company's long-term debt to total asset ratio is 0.6849, showing that a large portion of the company's assets are financed by long-term debt.
3. The company's inventory turnover ratio is low (1.3855), indicating that Amgen Inc has difficulty selling its inventory. This again could indicate issues with product demand or production efficiency.

[Prediction & Analysis]:
Given the continuous increase in AMGN's stock price over the past four weeks and the lack of any significant recent news, it seems that the market may be overdue for a correction. Additionally, with the company's high debt to equity and long-term debt to total asset ratios, the stock might face downward pressure as investors may be concerned about the company's debt management strategy. Due to these potential concerns, I predict that Amgen's stock price will decrease by 1-2% in the next week. Although the company is performing well in terms of EPS and operating margin, its ongoing debt might overshadow these benefits in the investors' perspective, leading to a short-term correction in the stock price."
"[Company Introduction]:

Amgen Inc is a leading entity in the Biotechnology sector. Incorporated and publicly traded since 1983-06-17, the company has established its reputation as one of the key players in the market. As of today, Amgen Inc has a market capitalization of 180145.00 in USD, with 537.33 shares outstanding.

Amgen Inc operates primarily in the US, trading under the ticker AMGN on the NASDAQ NMS - GLOBAL MARKET. As a dominant force in the Biotechnology space, the company continues to innovate and drive progress within the industry.

From 2023-04-02 to 2023-04-09, AMGN's stock price increased from 230.63 to 241.67. News during this period are listed below:

No relative news reported.
From 2023-04-09 to 2023-04-16, AMGN's stock price decreased from 241.67 to 238.50. News during this period are listed below:

No relative news reported.
[Basic Financials]:

No basic financial reported.

Based on all the information before 2023-04-16, let's first analyze the positive developments and potential concerns for AMGN. Come up with 2-4 most important factors respectively and keep them concise. Most factors should be inferred from company related news. Then let's assume your prediction for next week (2023-04-16 to 2023-04-23) is down by 2-3%. Provide a summary analysis to support your prediction. The prediction result need to be inferred from your analysis at the end, and thus not appearing as a foundational factor of your analysis.","[Positive Developments]:
1. Over two weeks, the company's stock price saw a steady increase, going from 230.63 to a high of 241.67. This indicates positive investor sentiment.
2. As no negative news has been reported in recent weeks, it can be assumed that the company is stable with no major operational disruptions.

[Potential Concerns]:
1. In the week from 2023-04-09 to 2023-04-16, the stock price slightly decreased from 241.67 to 238.50. Although the change is not significant, it may denote the beginning of a downtrend.
2. Another concern is the lack of news related to the company. In general, this stagnation in the news cycle can sometimes lead to a decrease in market interest, potentially leading to a bearish sentiment.

[Prediction & Analysis]:
Considering the slight decrease in the stock price in the past week and the absence of news related to AMGN, a possible downtrend could be expected, as investors might shift their interest to more active stocks with recent developments and tangible progression. Thus, the AMGN stock price might experience a 2-3% decrease in the coming week. Furthermore, no financials have been reported, which could entail hidden issues or potential risk factors leading to a prospective drop in the stock price. Lastly, the overall assessment of the trends suggests a potentially bearish sentiment in the upcoming week leading to the forecasted decrease. Investors should observe market interest and news regarding AMGN in the following week closely."
"[Company Introduction]:

Amgen Inc is a leading entity in the Biotechnology sector. Incorporated and publicly traded since 1983-06-17, the company has established its reputation as one of the key players in the market. As of today, Amgen Inc has a market capitalization of 180145.00 in USD, with 537.33 shares outstanding.

Amgen Inc operates primarily in the US, trading under the ticker AMGN on the NASDAQ NMS - GLOBAL MARKET. As a dominant force in the Biotechnology space, the company continues to innovate and drive progress within the industry.

From 2023-04-02 to 2023-04-09, AMGN's stock price increased from 230.63 to 241.67. News during this period are listed below:

No relative news reported.
From 2023-04-09 to 2023-04-16, AMGN's stock price decreased from 241.67 to 238.50. News during this period are listed below:

No relative news reported.
From 2023-04-16 to 2023-04-23, AMGN's stock price decreased from 238.50 to 232.64. News during this period are listed below:

No relative news reported.
[Basic Financials]:

No basic financial reported.

Based on all the information before 2023-04-23, let's first analyze the positive developments and potential concerns for AMGN. Come up with 2-4 most important factors respectively and keep them concise. Most factors should be inferred from company related news. Then let's assume your prediction for next week (2023-04-23 to 2023-04-30) is down by 1-2%. Provide a summary analysis to support your prediction. The prediction result need to be inferred from your analysis at the end, and thus not appearing as a foundational factor of your analysis.","[Positive Developments]:
1. AMGN enjoyed a period of growth from April 2nd to April 9th, with their stock price rising from 230.63 to 241.67, indicating a positive market sentiment.
2. Given that no significant news has been reported for the company, AMGN's business operations remain stable during the observed period.

[Potential Concerns]:
1. Despite the initial increase in stock price, AMGN faced a subsequent drop from April 9th to April 23rd, moving from 241.67 to 232.64. This denotes a potential bearish market sentiment for the company's stock.
2. Since no new developments or news regarding AMGN were reported during this period, the company lacks immediate growth drivers to buoy the stock price.

[Prediction & Analysis]:
Given the recent pullback in the share price and the lack of any significant company news, it is predicted that AMGN's stock price would slightly drop in the following week by 1-2%. The absence of new developments may have investors looking elsewhere for growth opportunities, and thus potentially driving the selling pressure. However, given AMGN's reputation as a major player in the biotech market, it's unlikely that the stock price would drastically fall, hence the modest prediction of a 1-2% drop."
"[Company Introduction]:

Amgen Inc is a leading entity in the Biotechnology sector. Incorporated and publicly traded since 1983-06-17, the company has established its reputation as one of the key players in the market. As of today, Amgen Inc has a market capitalization of 180145.00 in USD, with 537.33 shares outstanding.

Amgen Inc operates primarily in the US, trading under the ticker AMGN on the NASDAQ NMS - GLOBAL MARKET. As a dominant force in the Biotechnology space, the company continues to innovate and drive progress within the industry.

From 2023-04-23 to 2023-04-30, AMGN's stock price decreased from 232.64 to 228.71. News during this period are listed below:

No relative news reported.
[Basic Financials]:

No basic financial reported.

Based on all the information before 2023-04-30, let's first analyze the positive developments and potential concerns for AMGN. Come up with 2-4 most important factors respectively and keep them concise. Most factors should be inferred from company related news. Then let's assume your prediction for next week (2023-04-30 to 2023-05-07) is down by 1-2%. Provide a summary analysis to support your prediction. The prediction result need to be inferred from your analysis at the end, and thus not appearing as a foundational factor of your analysis.","[Positive Developments]:
1. Amgen Inc has been a long-standing player in the Biotechnology sector, which gives them a wealth of experience and a strong foothold in the industry.
2. They have consistently driven innovation, which may result in potential upward movement in the near future if new products or advancements are announced.

[Potential Concerns]:
1. Lack of pertinent news regarding the company in the recent past could either mean that no significant developments are taking place or they are not being communicated effectively to investors.
2. The stock price has decreased in the previous week, from 232.64 to 228.71, without any clear rationale based on news or financial reports, which could indicate a downward trend.

[Prediction & Analysis]:

Based on current developments and potential concerns, I predict a moderate decrease in Amgen's stock price by 1-2% in the upcoming week. The absence of significant positive news and recent downward trend in stock price might lead to a lack of investor confidence, causing further drop. Nevertheless,Amgen's consistent presence and innovation in the Biotechnology space should contain any significant plummet. Investors should keep an eye on possible favorable news, such as, successful drug trials and financial reports which could change the course."
"[Company Introduction]:

Amgen Inc is a leading entity in the Biotechnology sector. Incorporated and publicly traded since 1983-06-17, the company has established its reputation as one of the key players in the market. As of today, Amgen Inc has a market capitalization of 180145.00 in USD, with 537.33 shares outstanding.

Amgen Inc operates primarily in the US, trading under the ticker AMGN on the NASDAQ NMS - GLOBAL MARKET. As a dominant force in the Biotechnology space, the company continues to innovate and drive progress within the industry.

From 2023-04-23 to 2023-04-30, AMGN's stock price decreased from 232.64 to 228.71. News during this period are listed below:

No relative news reported.
From 2023-04-30 to 2023-05-07, AMGN's stock price decreased from 228.71 to 225.65. News during this period are listed below:

No relative news reported.
[Basic Financials]:

No basic financial reported.

Based on all the information before 2023-05-07, let's first analyze the positive developments and potential concerns for AMGN. Come up with 2-4 most important factors respectively and keep them concise. Most factors should be inferred from company related news. Then let's assume your prediction for next week (2023-05-07 to 2023-05-14) is down by 1-2%. Provide a summary analysis to support your prediction. The prediction result need to be inferred from your analysis at the end, and thus not appearing as a foundational factor of your analysis.","[Positive Developments]:
1. There are no significant reported problems or scandals associated with Amgen Inc. in the recent weeks, implying stable operations.
2. As a dominant force in the Biotechnology sector, its strong reputation and innovative streak are strategic assets.

[Potential Concerns]:
1. A continuous decline in the stock price in the last two weeks signifies a potential downtrend.
2. Without any recent news or financial reports to counterbalance the trend or point out new growth potentials, it's hard to foresee a positive outlook in the near future.
3. The market situation is unclear without financial data, making it more difficult to evaluate the company's recent performance.

[Prediction & Analysis]:

Based on the lack of positive news catalysts and persistent declining trend without explanatory variables, the outlook for the next week's stock price is bearish. The stock market usually moves first before news is reported, therefore, it might be that the market already sensed some between-the-lines information, which has not been made public yet. Furthermore, since the basic financials are unavailable, the ongoing down trend seems to be the only evaluation basis. Hence, my prediction is that Amgen Inc.'s stock price will experience a decrease of 1-2% during the week of May 7 to May 14, 2023. Investors are encouraged to be vigilant about possible news releasing in the forthcoming weeks that may affect the stock's performance."
"[Company Introduction]:

Amgen Inc is a leading entity in the Biotechnology sector. Incorporated and publicly traded since 1983-06-17, the company has established its reputation as one of the key players in the market. As of today, Amgen Inc has a market capitalization of 180145.00 in USD, with 537.33 shares outstanding.

Amgen Inc operates primarily in the US, trading under the ticker AMGN on the NASDAQ NMS - GLOBAL MARKET. As a dominant force in the Biotechnology space, the company continues to innovate and drive progress within the industry.

From 2023-04-16 to 2023-04-23, AMGN's stock price decreased from 238.50 to 232.64. News during this period are listed below:

No relative news reported.
From 2023-04-23 to 2023-04-30, AMGN's stock price decreased from 232.64 to 228.71. News during this period are listed below:

No relative news reported.
From 2023-04-30 to 2023-05-07, AMGN's stock price decreased from 228.71 to 225.65. News during this period are listed below:

No relative news reported.
From 2023-05-07 to 2023-05-14, AMGN's stock price decreased from 225.65 to 222.23. News during this period are listed below:

No relative news reported.
[Basic Financials]:

No basic financial reported.

Based on all the information before 2023-05-14, let's first analyze the positive developments and potential concerns for AMGN. Come up with 2-4 most important factors respectively and keep them concise. Most factors should be inferred from company related news. Then let's assume your prediction for next week (2023-05-14 to 2023-05-21) is down by 3-4%. Provide a summary analysis to support your prediction. The prediction result need to be inferred from your analysis at the end, and thus not appearing as a foundational factor of your analysis.","[Positive Developments]:
1. Given the lack of significant news about Amgen Inc, it's likely that the fundamentals of the company remain solid. 
2. The consistent commitment of Amgen to innovation and progress in the Biotechnology industry.

[Potential Concerns]:
1. There has been a steady decrease in the stocks' price over the several weeks despite no adverse news, indicating a potentially bearish sentiment among investors. 
2. The absence of financials or other company events may suggest a lack of transparency which could be cause for concern among potential investors.
3. Market sentiment towards biotech genetical stocks has been somewhat bearish due to regulatory concerns. 

[Prediction & Analysis]:

The lack of significant news about AMGN means that market sentiment and standard trading activity are likely the main factors behind its recent stock price behavior. Given the observed bearish bias in the trend of this stock in recent weeks, it is reasonable to predict that this downward trend could persist in the upcoming week. Furthermore, general market sentiment towards biotech stocks has been skewed to the downside recently, due to concerns over tighter regulations, which could also put some downward pressure on the price. Therefore I would suggest a downward prediction of 3-4% for AMGN's stock price in the upcoming week (2023-05-14 to 2023-05-21)."
"[Company Introduction]:

Amgen Inc is a leading entity in the Biotechnology sector. Incorporated and publicly traded since 1983-06-17, the company has established its reputation as one of the key players in the market. As of today, Amgen Inc has a market capitalization of 180145.00 in USD, with 537.33 shares outstanding.

Amgen Inc operates primarily in the US, trading under the ticker AMGN on the NASDAQ NMS - GLOBAL MARKET. As a dominant force in the Biotechnology space, the company continues to innovate and drive progress within the industry.

From 2023-05-14 to 2023-05-21, AMGN's stock price decreased from 222.23 to 215.15. News during this period are listed below:

No relative news reported.
[Basic Financials]:

No basic financial reported.

Based on all the information before 2023-05-21, let's first analyze the positive developments and potential concerns for AMGN. Come up with 2-4 most important factors respectively and keep them concise. Most factors should be inferred from company related news. Then let's assume your prediction for next week (2023-05-21 to 2023-05-28) is down by 2-3%. Provide a summary analysis to support your prediction. The prediction result need to be inferred from your analysis at the end, and thus not appearing as a foundational factor of your analysis.","[Positive Developments]:
1. Strong reputation: Amgen Inc holds a powerful position in the biotech market, leading and innovating in its industry.
2. Established history: The company has a well-grounded history with over 40 years in the market.

[Potential Concerns]:
1. Lack of news: No significant company-related news has been reported recently, which can sometimes lead to investor uncertainty and selling in the absence of reassurances on strategy and results.
2. Negative price trend: The company's stock price decreased from 222.23 to 215.15 in the previous week. This may be seen as a concerning development for shareholders and potential investors.
3. Lack of financial information: The absence of recent financial reports could cause concern to investors expecting transparency in terms of company performance.

[Prediction & Analysis]:

Given the lack of fresh company-related news, and with no recent financials to gauge the business performance, it is hard to make granular predictions about the company. However, considering the downward trend seen in the most recent week, it is reasonable to expect this trend to continue in the short term. Therefore, the stock price may decrease by 2-3% in the following week. As a reputable player in the field, Amgen may be able to rebound from this temporary decrease, especially if fresh positive news or financial results come to light."
"[Company Introduction]:

Amgen Inc is a leading entity in the Biotechnology sector. Incorporated and publicly traded since 1983-06-17, the company has established its reputation as one of the key players in the market. As of today, Amgen Inc has a market capitalization of 180145.00 in USD, with 537.33 shares outstanding.

Amgen Inc operates primarily in the US, trading under the ticker AMGN on the NASDAQ NMS - GLOBAL MARKET. As a dominant force in the Biotechnology space, the company continues to innovate and drive progress within the industry.

From 2023-05-07 to 2023-05-14, AMGN's stock price decreased from 225.65 to 222.23. News during this period are listed below:

No relative news reported.
From 2023-05-14 to 2023-05-21, AMGN's stock price decreased from 222.23 to 215.15. News during this period are listed below:

No relative news reported.
From 2023-05-21 to 2023-05-28, AMGN's stock price decreased from 215.15 to 208.90. News during this period are listed below:

No relative news reported.
[Basic Financials]:

No basic financial reported.

Based on all the information before 2023-05-28, let's first analyze the positive developments and potential concerns for AMGN. Come up with 2-4 most important factors respectively and keep them concise. Most factors should be inferred from company related news. Then let's assume your prediction for next week (2023-05-28 to 2023-06-04) is up by 0-1%. Provide a summary analysis to support your prediction. The prediction result need to be inferred from your analysis at the end, and thus not appearing as a foundational factor of your analysis.","[Positive Developments]:
1. Despite the decrease in stock price over the last few weeks, there were no significant negative news or reports related to the company or its operations. This may suggest external market factors are affecting the stock's performance rather than internal issues.

[Potential Concerns]:
1. Lack of Positive News: In the period reviewed, there was a total absence of any news related to Amgen Inc. This lack of visibility could be a concern, as it allows external market forces and speculation to impact the stock's performance.

2. Continuous Decrease in Stock Price: Despite an absence of negative news specifically related to Amgen Inc., the stock price has shown a consistent decrease over the past weeks. This steady downwards trend could be a signal to investors that other factors, which may not have been revealed yet, are affecting the company.

[Prediction & Analysis]:

Given there is no relative news reported and no basic financials revealed over the last period, the decrease in the stock price could be attributed to wider market trends rather than company-specific factors. In addition, as a reputable player in the Biotechnology sector, Amgen Inc has a solid standing in the industry and a history of resilience. Therefore, considering these factors, I predict a stability in the stock price with a slight upward movement of around 0-1% for the upcoming week from May 28 to June 04, 2023, as the market stabilizes and potentially adjusts for the recent decrease."
"[Company Introduction]:

Amgen Inc is a leading entity in the Biotechnology sector. Incorporated and publicly traded since 1983-06-17, the company has established its reputation as one of the key players in the market. As of today, Amgen Inc has a market capitalization of 180145.00 in USD, with 537.33 shares outstanding.

Amgen Inc operates primarily in the US, trading under the ticker AMGN on the NASDAQ NMS - GLOBAL MARKET. As a dominant force in the Biotechnology space, the company continues to innovate and drive progress within the industry.

From 2023-05-21 to 2023-05-28, AMGN's stock price decreased from 215.15 to 208.90. News during this period are listed below:

No relative news reported.
From 2023-05-28 to 2023-06-04, AMGN's stock price increased from 208.90 to 210.00. News during this period are listed below:

No relative news reported.
[Basic Financials]:

No basic financial reported.

Based on all the information before 2023-06-04, let's first analyze the positive developments and potential concerns for AMGN. Come up with 2-4 most important factors respectively and keep them concise. Most factors should be inferred from company related news. Then let's assume your prediction for next week (2023-06-04 to 2023-06-11) is up by 0-1%. Provide a summary analysis to support your prediction. The prediction result need to be inferred from your analysis at the end, and thus not appearing as a foundational factor of your analysis.","[Positive Developments]:
1. The company's stock price has slightly increased from $208.90 to $210.00 within the last week – a sign of some positive momentum.
2. Despite the overall decline from $215.15 to $210.00 during the last few weeks, the company's stock price has shown a modest rebound, suggesting resilience.

[Potential Concerns]:
1. Lack of company-specific news might indicate limited catalysts for significant upward movement in the stock price.
2. Absence of financial reports can create uncertainties regarding the company's current financial position and performance.
3. The downward trend from $215.15 to $208.90 in the week prior to the last week might signal bearish investor sentiment.

[Prediction & Analysis]:

The slight increase in Amgen's stock price over the last week could be interpreted as a modest sign of investor confidence. However, without any compelling catalysts in the form of positive company-specific news or recent financial reports to foster more substantial upward momentum, any appreciable rise in the stock price may be unlikely in the week ahead. Therefore, I predict Amgen's stock price to increase by 0-1% from 2023-06-04 to 2023-06-11. This is based on the assumption that continual resilience in the face of minor setbacks, as demonstrated in the last week, will provide the necessary stability for a slight increase. However, it's also worth bearing in mind that lack of transparency into the company's financials and potential bearish sentiment could maintain the stock in a somewhat stagnant state."
"[Company Introduction]:

Amgen Inc is a leading entity in the Biotechnology sector. Incorporated and publicly traded since 1983-06-17, the company has established its reputation as one of the key players in the market. As of today, Amgen Inc has a market capitalization of 180145.00 in USD, with 537.33 shares outstanding.

Amgen Inc operates primarily in the US, trading under the ticker AMGN on the NASDAQ NMS - GLOBAL MARKET. As a dominant force in the Biotechnology space, the company continues to innovate and drive progress within the industry.

From 2023-05-21 to 2023-05-28, AMGN's stock price decreased from 215.15 to 208.90. News during this period are listed below:

No relative news reported.
From 2023-05-28 to 2023-06-04, AMGN's stock price increased from 208.90 to 210.00. News during this period are listed below:

No relative news reported.
From 2023-06-04 to 2023-06-11, AMGN's stock price increased from 210.00 to 210.67. News during this period are listed below:

No relative news reported.
[Basic Financials]:

No basic financial reported.

Based on all the information before 2023-06-11, let's first analyze the positive developments and potential concerns for AMGN. Come up with 2-4 most important factors respectively and keep them concise. Most factors should be inferred from company related news. Then let's assume your prediction for next week (2023-06-11 to 2023-06-18) is up by 4-5%. Provide a summary analysis to support your prediction. The prediction result need to be inferred from your analysis at the end, and thus not appearing as a foundational factor of your analysis.","[Positive Developments]:
1. The consistent increase in stock price over the past weeks indicates a positive sentiment amongst investors. 

2. The absence of negative news demonstrates a stable operating environment for the company, enabling it to focus on current projects and initiatives.

[Potential Concerns]:
1. Lack of significant positive news during past weeks could suggest the company might not have any recent innovative development or significant revenue generation activities.

2. There are no reported basic financials for the company, which might raise questions about fiscal transparency and whether the current stock price accurately represents the company's value.

[Prediction & Analysis]:

Despite the absence of fresh news catalysts in recent weeks and lack of disclosed financial information, AMGN's stock price has demonstrated a steady increasing trend. This suggests that market sentiment and trust in the company's long-term strategy remain strong. Additionally, the company's established reputation in the Biotechnology sector provides a degree of stability.

However, the lack of recent news or updates about the company could cause investors to consider whether the stock is currently overvalued. Still, based on its ongoing stability and a mildly ascending trend, I would suggest that the stock price might continue on this path, but with a smaller increment due to potential concerns, resulting in an approximately 4-5% increase in the upcoming week. An unexpected company announcement or market event could significantly affect this prediction."
"[Company Introduction]:

Amgen Inc is a leading entity in the Biotechnology sector. Incorporated and publicly traded since 1983-06-17, the company has established its reputation as one of the key players in the market. As of today, Amgen Inc has a market capitalization of 180145.00 in USD, with 537.33 shares outstanding.

Amgen Inc operates primarily in the US, trading under the ticker AMGN on the NASDAQ NMS - GLOBAL MARKET. As a dominant force in the Biotechnology space, the company continues to innovate and drive progress within the industry.

From 2023-05-21 to 2023-05-28, AMGN's stock price decreased from 215.15 to 208.90. News during this period are listed below:

No relative news reported.
From 2023-05-28 to 2023-06-04, AMGN's stock price increased from 208.90 to 210.00. News during this period are listed below:

No relative news reported.
From 2023-06-04 to 2023-06-11, AMGN's stock price increased from 210.00 to 210.67. News during this period are listed below:

No relative news reported.
From 2023-06-11 to 2023-06-18, AMGN's stock price increased from 210.67 to 221.16. News during this period are listed below:

No relative news reported.
[Basic Financials]:

No basic financial reported.

Based on all the information before 2023-06-18, let's first analyze the positive developments and potential concerns for AMGN. Come up with 2-4 most important factors respectively and keep them concise. Most factors should be inferred from company related news. Then let's assume your prediction for next week (2023-06-18 to 2023-06-25) is down by 1-2%. Provide a summary analysis to support your prediction. The prediction result need to be inferred from your analysis at the end, and thus not appearing as a foundational factor of your analysis.","[Positive Developments]:
1. Over the past weeks, AMGN's stock price has demonstrated a general upward trend, indicating positive investor sentiment.
2. The absence of negative news or rumors also could suggest the absence of major setbacks or obstacles for the company.

[Potential Concerns]:
1. Without any relative news or current basic financials reported, it's difficult to validate the sustainability of this upward movement.
2. The market can be volatile and even without bad news, stock prices may experience correction after a period of growth.

[Prediction & Analysis]:

The generality of the stock market may act based on news and core financial metrics. However, the lack of these details for Amgen Inc in recent weeks doesn't provide enough insights to fully substantiate the observed increase in their stock prices. In lieu of specific driving factors propelling its upward trend, the stock may be overvalued and due for a correction. Therefore, I predict a slight decrease of 1-2% in AMGN's stock price for the week of 2023-06-18 to 2023-06-25 as the market readjusts. Keep in mind that market volatility can also play a significant role and this prediction is based on current known information."
"[Company Introduction]:

Amgen Inc is a leading entity in the Biotechnology sector. Incorporated and publicly traded since 1983-06-17, the company has established its reputation as one of the key players in the market. As of today, Amgen Inc has a market capitalization of 180145.00 in USD, with 537.33 shares outstanding.

Amgen Inc operates primarily in the US, trading under the ticker AMGN on the NASDAQ NMS - GLOBAL MARKET. As a dominant force in the Biotechnology space, the company continues to innovate and drive progress within the industry.

From 2023-06-11 to 2023-06-18, AMGN's stock price increased from 210.67 to 221.16. News during this period are listed below:

No relative news reported.
From 2023-06-18 to 2023-06-25, AMGN's stock price decreased from 221.16 to 218.71. News during this period are listed below:

No relative news reported.
Some recent basic financials of AMGN, reported at 2023-06-30, are presented below:

[Basic Financials]:

assetTurnoverTTM: 0.3454
bookValue: 6781
cashRatio: 2.0031584488506757
currentRatio: 2.7712
ebitPerShare: 4.9981
eps: 2.568
ev: 146076.7
fcfMargin: 0.5494
fcfPerShareTTM: 18.1028
grossMargin: 0.7405
inventoryTurnoverTTM: 1.4331
longtermDebtTotalAsset: 0.6578
longtermDebtTotalCapital: 0.869
longtermDebtTotalEquity: 8.7564
netDebtToTotalCapital: 0.3995
netDebtToTotalEquity: 4.0254
netMargin: 0.1974
operatingMargin: 0.3842
payoutRatioTTM: 0.5457
pb: 17.5167
peTTM: 14.8867
pfcfTTM: 12.2644
pretaxMargin: 0.231
psTTM: 4.4685
quickRatio: 2.4801
receivablesTurnoverTTM: 4.7651
roaTTM: 0.1037
roeTTM: 1.6415
roicTTM: 0.1449
rotcTTM: 0.1759
salesPerShare: 13.0093
sgaToSale: 0.2595
totalDebtToEquity: 9.0759
totalDebtToTotalAsset: 0.6818
totalDebtToTotalCapital: 0.9008
totalRatio: 1.0812

Based on all the information before 2023-06-25, let's first analyze the positive developments and potential concerns for AMGN. Come up with 2-4 most important factors respectively and keep them concise. Most factors should be inferred from company related news. Then let's assume your prediction for next week (2023-06-25 to 2023-07-02) is down by 2-3%. Provide a summary analysis to support your prediction. The prediction result need to be inferred from your analysis at the end, and thus not appearing as a foundational factor of your analysis.","[Positive Developments]:
1. Amgen enjoys a robust ebitPerShare of 4.9981, indicating efficient operations and profitability.
2. A high gross margin of 0.7405 and operating margin of 0.3842 suggest good profit potential from its operations.
3. Fairly healthy financial ratios like quickRatio 2.4801 and currentRatio 2.7712 showing company's ability to pay its short-term obligations.
4. Good salesPerShare of 13.0093 suggests potent sales strategies and could potentially lead to higher profits.

[Potential Concerns]:
1. Very high debt indicators, with longtermDebtTotalEquity at 8.7564, totalDebtToEquity at 9.0759, and totalDebtToTotalAsset at 0.6818, suggest the business is heavily leveraged and could be at risk in market downturns.
2. Relatively low inventoryTurnoverTTM of 1.4331, reflecting inefficiency in inventory management leading to tied-up assets and increased carrying costs.
3. The debt ratios indicate high financial risk which could dilute shareholder returns and company's freedom to operate in the future.
4. The current high price earnings ratio(peTTM: 14.8867) could suggest the stock is overvalued.

[Prediction & Analysis]:
Given the concerning debt figures and potential inefficiency in supply management, there seems to be more risk associated with Amgen Inc. This, coupled with a high P/E ratio, might lead investors to question the company's current value. On top, no significant positive news about the company has been reported in recent weeks which in turn may impact investor sentiment negatively. Comparing the positive developments and the potential concerns, the latter seem to be more prevalent in the current situation. Thus, I predict that the price of Amgen Inc.'s stock may decrease by around 2-3% in the following week (2023-06-25 to 2023-07-02)."
"[Company Introduction]:

Amgen Inc is a leading entity in the Biotechnology sector. Incorporated and publicly traded since 1983-06-17, the company has established its reputation as one of the key players in the market. As of today, Amgen Inc has a market capitalization of 180145.00 in USD, with 537.33 shares outstanding.

Amgen Inc operates primarily in the US, trading under the ticker AMGN on the NASDAQ NMS - GLOBAL MARKET. As a dominant force in the Biotechnology space, the company continues to innovate and drive progress within the industry.

From 2023-06-25 to 2023-07-02, AMGN's stock price decreased from 218.71 to 213.80. News during this period are listed below:

No relative news reported.
Some recent basic financials of AMGN, reported at 2023-06-30, are presented below:

[Basic Financials]:

assetTurnoverTTM: 0.3454
bookValue: 6781
cashRatio: 2.0031584488506757
currentRatio: 2.7712
ebitPerShare: 4.9981
eps: 2.568
ev: 146076.7
fcfMargin: 0.5494
fcfPerShareTTM: 18.1028
grossMargin: 0.7405
inventoryTurnoverTTM: 1.4331
longtermDebtTotalAsset: 0.6578
longtermDebtTotalCapital: 0.869
longtermDebtTotalEquity: 8.7564
netDebtToTotalCapital: 0.3995
netDebtToTotalEquity: 4.0254
netMargin: 0.1974
operatingMargin: 0.3842
payoutRatioTTM: 0.5457
pb: 17.5167
peTTM: 14.8867
pfcfTTM: 12.2644
pretaxMargin: 0.231
psTTM: 4.4685
quickRatio: 2.4801
receivablesTurnoverTTM: 4.7651
roaTTM: 0.1037
roeTTM: 1.6415
roicTTM: 0.1449
rotcTTM: 0.1759
salesPerShare: 13.0093
sgaToSale: 0.2595
totalDebtToEquity: 9.0759
totalDebtToTotalAsset: 0.6818
totalDebtToTotalCapital: 0.9008
totalRatio: 1.0812

Based on all the information before 2023-07-02, let's first analyze the positive developments and potential concerns for AMGN. Come up with 2-4 most important factors respectively and keep them concise. Most factors should be inferred from company related news. Then let's assume your prediction for next week (2023-07-02 to 2023-07-09) is down by 1-2%. Provide a summary analysis to support your prediction. The prediction result need to be inferred from your analysis at the end, and thus not appearing as a foundational factor of your analysis.","[Positive Developments]:
1. Amgen Inc has a solid book value reported at 6781 as of 2023-06-30. This suggests a robust fundamental footing for the company.
2. The firm's profit margins appear to be healthy, with a gross margin of 0.7405 and a net margin of 0.1974. This implies strong pricing power and operational efficiency.
3. The company has consistently demonstrated good cash flow management. The cash ratio is 2.0031584488506757, indicating capability to cover short term liabilities. 

[Potential Concerns]:
1. The company's long-term debt to total asset ratio and debt to equity ratio are relatively high, suggesting a high level of borrowed capital and potential financial risk.
2. The company has a relatively low inventory turnover of 1.4331. This could potentially indicate issues with inventory management or sluggish sales.
3. Despite Amgen Inc.'s good cash flow management, its payout ratio TTM is 0.5457, which could put pressure on available funds for reinvestment or to cover unexpected costs.

[Prediction & Analysis]:
Overall, while Amgen Inc. has demonstrated strong fundamentals and solid profit margins, concerns about financial risk from its high debt ratios and potential inventory management issues may be impacting investor confidence. This combination of strengths and weaknesses could indicate a minor pullback in the stock in the short term while the company addresses these concerns. Therefore, a likely prediction for the stock price movement for the upcoming week could be a decrease of 1-2%."
"[Company Introduction]:

Amgen Inc is a leading entity in the Biotechnology sector. Incorporated and publicly traded since 1983-06-17, the company has established its reputation as one of the key players in the market. As of today, Amgen Inc has a market capitalization of 180145.00 in USD, with 537.33 shares outstanding.

Amgen Inc operates primarily in the US, trading under the ticker AMGN on the NASDAQ NMS - GLOBAL MARKET. As a dominant force in the Biotechnology space, the company continues to innovate and drive progress within the industry.

From 2023-06-11 to 2023-06-18, AMGN's stock price increased from 210.67 to 221.16. News during this period are listed below:

No relative news reported.
From 2023-06-18 to 2023-06-25, AMGN's stock price decreased from 221.16 to 218.71. News during this period are listed below:

No relative news reported.
From 2023-06-25 to 2023-07-02, AMGN's stock price decreased from 218.71 to 213.80. News during this period are listed below:

No relative news reported.
From 2023-07-02 to 2023-07-09, AMGN's stock price decreased from 213.80 to 210.56. News during this period are listed below:

No relative news reported.
Some recent basic financials of AMGN, reported at 2023-06-30, are presented below:

[Basic Financials]:

assetTurnoverTTM: 0.3454
bookValue: 6781
cashRatio: 2.0031584488506757
currentRatio: 2.7712
ebitPerShare: 4.9981
eps: 2.568
ev: 146076.7
fcfMargin: 0.5494
fcfPerShareTTM: 18.1028
grossMargin: 0.7405
inventoryTurnoverTTM: 1.4331
longtermDebtTotalAsset: 0.6578
longtermDebtTotalCapital: 0.869
longtermDebtTotalEquity: 8.7564
netDebtToTotalCapital: 0.3995
netDebtToTotalEquity: 4.0254
netMargin: 0.1974
operatingMargin: 0.3842
payoutRatioTTM: 0.5457
pb: 17.5167
peTTM: 14.8867
pfcfTTM: 12.2644
pretaxMargin: 0.231
psTTM: 4.4685
quickRatio: 2.4801
receivablesTurnoverTTM: 4.7651
roaTTM: 0.1037
roeTTM: 1.6415
roicTTM: 0.1449
rotcTTM: 0.1759
salesPerShare: 13.0093
sgaToSale: 0.2595
totalDebtToEquity: 9.0759
totalDebtToTotalAsset: 0.6818
totalDebtToTotalCapital: 0.9008
totalRatio: 1.0812

Based on all the information before 2023-07-09, let's first analyze the positive developments and potential concerns for AMGN. Come up with 2-4 most important factors respectively and keep them concise. Most factors should be inferred from company related news. Then let's assume your prediction for next week (2023-07-09 to 2023-07-16) is up by 4-5%. Provide a summary analysis to support your prediction. The prediction result need to be inferred from your analysis at the end, and thus not appearing as a foundational factor of your analysis.","[Positive Developments]:
1. No bad news reported recently: Over the past weeks, there has been no reported negative news about AMGN, suggesting that the company operates continuously without major disruptions.
2. Robust Financials: The company reports healthy figures with a gross margin of 0.7405 indicating effective management of the cost of goods sold, and a notable FCF per share TTM at 18.1028.

[Potential Concerns]:
1. Stock Price Trend: Over the past month, AMGN’s stock price has been consistently decreasing. This downward trend might deter some investment as it suggests declining investor confidence or market interest.
2. High level of debt to equity: With the value of totalDebtToEquity being 9.0759, it indicates a relatively high level of financial risk that the company can face in the long term.

[Prediction & Analysis]:

Despite the recent downward trend in stock prices, AMGN's robust financial performance, marked by a healthy gross margin and remarkable FCF per share TTM, suggests a productive business operation. The absence of negative news in the recent weeks underpins stability in its day-to-day activities. Although potential concerns exist, such as a high level of debt to equity, it's a common characteristic in the biotechnology sector, largely in place to fund costly research and development. The stock price decrease is likely to be a market correction, making the company shares undervalued. Given this, for the upcoming week from 2023-07-09 to 2023-07-16, I predict the stock price of AMGN to rebound by approximately 4-5%."
"[Company Introduction]:

Amgen Inc is a leading entity in the Biotechnology sector. Incorporated and publicly traded since 1983-06-17, the company has established its reputation as one of the key players in the market. As of today, Amgen Inc has a market capitalization of 180145.00 in USD, with 537.33 shares outstanding.

Amgen Inc operates primarily in the US, trading under the ticker AMGN on the NASDAQ NMS - GLOBAL MARKET. As a dominant force in the Biotechnology space, the company continues to innovate and drive progress within the industry.

From 2023-06-25 to 2023-07-02, AMGN's stock price decreased from 218.71 to 213.80. News during this period are listed below:

No relative news reported.
From 2023-07-02 to 2023-07-09, AMGN's stock price decreased from 213.80 to 210.56. News during this period are listed below:

No relative news reported.
From 2023-07-09 to 2023-07-16, AMGN's stock price increased from 210.56 to 219.01. News during this period are listed below:

No relative news reported.
[Basic Financials]:

No basic financial reported.

Based on all the information before 2023-07-16, let's first analyze the positive developments and potential concerns for AMGN. Come up with 2-4 most important factors respectively and keep them concise. Most factors should be inferred from company related news. Then let's assume your prediction for next week (2023-07-16 to 2023-07-23) is up by 3-4%. Provide a summary analysis to support your prediction. The prediction result need to be inferred from your analysis at the end, and thus not appearing as a foundational factor of your analysis.","[Positive Developments]:
1. Steady historical performance: AMGN has consistently remained at the forefront of the Biotechnology sector, reflecting strong operational and managerial effectiveness even in the absence of significant news events.
2. Strong market position: AMGN's vast size—demonstrated by its substantial market capitalization suggests that it is deeply entrenched in the market, likely securing a stable revenue stream.
3. Absence of negative news: Over the past few weeks, there has been no negative news reported, which is good news in and of itself for AMGN.

[Potential Concerns]:
1. Lack of growth catalysts: With no recent news reported – positive or negative – there's a lack of clear growth catalysts that could propel AMGN's stock higher.
2. Recent downtrends: Despite a brief recovery, the stock has been trending downwards for a couple of weeks, suggesting that some investors may be losing confidence.

[Prediction & Analysis]:

Despite the concerns, a few positive developments may put AMGN on track for a modest rise in the following week. The company's strong market position and absence of negative news provide a solid backing for potential growth. Nevertheless, without newsworthy events—be they product launches or positive financial reports—investors could potentially question the stock's short-term growth potential.

The absence of adverse news or major sectoral changes may allow AMGN's stock price to recover as steady behind-the-scenes operations continue to drive the company. Furthermore, the stock's recent recovery suggests that there may be latent investor interest that could be harnessed in days to come.

In conclusion, for the week of 2023-07-16 to 2023-07-23, we predict AMGN's stock price may experience a rise of around 3-4% given its stability and the potential for rebound from recent downturns. The lack of negative news and AMGN's powerful presence within its sector could just be enough to restore investor confidence, despite the absence of obvious growth catalysts. However, given the stock's recent uneven trajectory, investors should keep a close eye on any emerging trends or news concerning the company."
"[Company Introduction]:

Amgen Inc is a leading entity in the Biotechnology sector. Incorporated and publicly traded since 1983-06-17, the company has established its reputation as one of the key players in the market. As of today, Amgen Inc has a market capitalization of 180145.00 in USD, with 537.33 shares outstanding.

Amgen Inc operates primarily in the US, trading under the ticker AMGN on the NASDAQ NMS - GLOBAL MARKET. As a dominant force in the Biotechnology space, the company continues to innovate and drive progress within the industry.

From 2023-07-09 to 2023-07-16, AMGN's stock price increased from 210.56 to 219.01. News during this period are listed below:

No relative news reported.
From 2023-07-16 to 2023-07-23, AMGN's stock price increased from 219.01 to 226.13. News during this period are listed below:

No relative news reported.
[Basic Financials]:

No basic financial reported.

Based on all the information before 2023-07-23, let's first analyze the positive developments and potential concerns for AMGN. Come up with 2-4 most important factors respectively and keep them concise. Most factors should be inferred from company related news. Then let's assume your prediction for next week (2023-07-23 to 2023-07-30) is up by 0-1%. Provide a summary analysis to support your prediction. The prediction result need to be inferred from your analysis at the end, and thus not appearing as a foundational factor of your analysis.","[Positive Developments]:
1. There is a consistent upward trend in Amgen Inc's stock price in the recent weeks, indicating a positive sentiment among investors.
2. Absence of negative news might contribute to the stability and positive outlook of the stock.

[Potential Concerns]:
1. Lack of company-specific news during these periods means that we're unable to determine the specific drivers behind the stock's recent performance.
2. Absence of basic financials hampers a comprehensive analysis of the company's financial health.

[Prediction & Analysis]:

Given the lack of specific news and basic financial data, our analysis is based primarily on the recent upward trend in the company's stock price. The sustained upward movement, albeit moderate, may suggest steady investor confidence and market sentiment towards the company. However, it's also essential to be mindful of the absence of concrete news that might justify these price increases.

Consequently, we predict a modest upward movement of 0-1% for Amgen Inc's stock price in the next trading week. Nonetheless, potential investors should actively monitor any forthcoming financial data or company news that may impact this prediction. Further, they should conduct a more detailed analysis of the company's long-term financial health and broader biotechnology market trends before making investment decisions."
"[Company Introduction]:

Amgen Inc is a leading entity in the Biotechnology sector. Incorporated and publicly traded since 1983-06-17, the company has established its reputation as one of the key players in the market. As of today, Amgen Inc has a market capitalization of 180145.00 in USD, with 537.33 shares outstanding.

Amgen Inc operates primarily in the US, trading under the ticker AMGN on the NASDAQ NMS - GLOBAL MARKET. As a dominant force in the Biotechnology space, the company continues to innovate and drive progress within the industry.

From 2023-07-09 to 2023-07-16, AMGN's stock price increased from 210.56 to 219.01. News during this period are listed below:

No relative news reported.
From 2023-07-16 to 2023-07-23, AMGN's stock price increased from 219.01 to 226.13. News during this period are listed below:

No relative news reported.
From 2023-07-23 to 2023-07-30, AMGN's stock price increased from 226.13 to 227.62. News during this period are listed below:

No relative news reported.
[Basic Financials]:

No basic financial reported.

Based on all the information before 2023-07-30, let's first analyze the positive developments and potential concerns for AMGN. Come up with 2-4 most important factors respectively and keep them concise. Most factors should be inferred from company related news. Then let's assume your prediction for next week (2023-07-30 to 2023-08-06) is up by 2-3%. Provide a summary analysis to support your prediction. The prediction result need to be inferred from your analysis at the end, and thus not appearing as a foundational factor of your analysis.","[Positive Developments]:
1. AMGN's stock price has been on a continuous upward trend from 210.56 to 227.62 over the period of 2023-07-09 to 2023-07-30.
2. The lack of negative news indicates that business operations likely remain stable and are not facing significant challenges or controversies.

[Potential Concerns]:
1. The absence of company-related news could suggest the company is not making significant advancements or news-worthy undertakings, which could eventually put its leadership position at risk.
2. No basic financials reported, making it harder to make an accurate assessment of the company's financial health and future prospects.

[Prediction & Analysis]:

Despite the lack of news, Amgen Inc's steady and continuous stock price increase over the last three weeks suggests bullish investor sentiment, underpinned by its reputation as a leader in the biotechnology sector. Thus, for the week of 2023-07-30 to 2023-08-06, the stock price is expected to follow its ongoing upward trend, potentially increasing by 2-3%. However, the lack of reported basic financials and any significant news remains a concern and investors should stay alert to changes in this front."
"[Company Introduction]:

Amgen Inc is a leading entity in the Biotechnology sector. Incorporated and publicly traded since 1983-06-17, the company has established its reputation as one of the key players in the market. As of today, Amgen Inc has a market capitalization of 180145.00 in USD, with 537.33 shares outstanding.

Amgen Inc operates primarily in the US, trading under the ticker AMGN on the NASDAQ NMS - GLOBAL MARKET. As a dominant force in the Biotechnology space, the company continues to innovate and drive progress within the industry.

From 2023-07-30 to 2023-08-06, AMGN's stock price increased from 227.62 to 234.28. News during this period are listed below:

No relative news reported.
[Basic Financials]:

No basic financial reported.

Based on all the information before 2023-08-06, let's first analyze the positive developments and potential concerns for AMGN. Come up with 2-4 most important factors respectively and keep them concise. Most factors should be inferred from company related news. Then let's assume your prediction for next week (2023-08-06 to 2023-08-13) is up by more than 5%. Provide a summary analysis to support your prediction. The prediction result need to be inferred from your analysis at the end, and thus not appearing as a foundational factor of your analysis.","[Positive Developments]:
1. Amgen Inc.'s stock price has demonstrated a positive upward trend over the past week, indicating investor confidence and a healthy financial status for the company.
2. The lack of negative news could suggest that the company has been maintaining its operations well, keeping risks and issues under control.

[Potential Concerns]:
1. With no concrete news or financial information available, uncertainties may arise about the company's future management strategy and operational status.
2. The lack of basic financials makes it hard to analyze the company’s business performance, casting a shadow over its potential for sustained growth.

[Prediction & Analysis]:

Although no specific news or major financial data has been reported in recent weeks, Amgen Inc.'s stock price has shown a steady upward trend, increasing from $227.62 to $234.28. Despite the lack of news, the market perceives the company in a positive light, leading to the rise in the stock price. This stability in stock price growth, coupled with the absence of negative news, could suggest sound financial management within the company and promising prospects.

Given the current status, it's plausible to predict a positive trend that may result in the stock price rising by more than 5% in the coming week. Market investors may be speculating on potential upcoming developments, which could build momentum in the stock's performance. Moreover, in the Biotechnology sector, innovation and technological improvement can often lead to sudden growth, further supporting the prediction of an upturn.

There's a certain risk attached to this prediction since it's made on the basis of a steady past performance, despite an absence of recent company news or financials. But given the strong track record and reputation of Amgen Inc. in the biotechnology sector, this prediction holds a reasonable chance of turning true. Investors are advised to stay updated on company news and manage their investments prudently."
"[Company Introduction]:

Amgen Inc is a leading entity in the Biotechnology sector. Incorporated and publicly traded since 1983-06-17, the company has established its reputation as one of the key players in the market. As of today, Amgen Inc has a market capitalization of 180145.00 in USD, with 537.33 shares outstanding.

Amgen Inc operates primarily in the US, trading under the ticker AMGN on the NASDAQ NMS - GLOBAL MARKET. As a dominant force in the Biotechnology space, the company continues to innovate and drive progress within the industry.

From 2023-07-30 to 2023-08-06, AMGN's stock price increased from 227.62 to 234.28. News during this period are listed below:

No relative news reported.
From 2023-08-06 to 2023-08-13, AMGN's stock price increased from 234.28 to 252.80. News during this period are listed below:

No relative news reported.
[Basic Financials]:

No basic financial reported.

Based on all the information before 2023-08-13, let's first analyze the positive developments and potential concerns for AMGN. Come up with 2-4 most important factors respectively and keep them concise. Most factors should be inferred from company related news. Then let's assume your prediction for next week (2023-08-13 to 2023-08-20) is up by 0-1%. Provide a summary analysis to support your prediction. The prediction result need to be inferred from your analysis at the end, and thus not appearing as a foundational factor of your analysis.","[Positive Developments]:
1. Continuous rise in AMGN's stock price over past weeks, demonstrating strong investor confidence.
2. The company is operating in biotechnology sector, which has been witnessing exponential growth.

[Potential Concerns]:
1. The lack of significant company news could indicate reduced transparency.
2. No basic financials have been reported, lowering confidence in business health evaluation.

[Prediction & Analysis]:

The upward trend in AMGN's stock price supports the prediction that AMGN shares will see a continued - if minimal - rise of 0-1% in the coming week. Despite lacking recent news or financial reporting data, the company's stable and growing position in the booming biotechnology sector reinforces this forecast. 

However, the absence of basic financials and notable company events does inject uncertainty into any projections. While the stock has shown robust performance in the past weeks, the lack of detailed insights into the company's current financial situation or potential upcoming obstacles tempers expectations for large gains. Therefore, small but ongoing increases in stock value seem the most probable scenario."
"[Company Introduction]:

Amgen Inc is a leading entity in the Biotechnology sector. Incorporated and publicly traded since 1983-06-17, the company has established its reputation as one of the key players in the market. As of today, Amgen Inc has a market capitalization of 180145.00 in USD, with 537.33 shares outstanding.

Amgen Inc operates primarily in the US, trading under the ticker AMGN on the NASDAQ NMS - GLOBAL MARKET. As a dominant force in the Biotechnology space, the company continues to innovate and drive progress within the industry.

From 2023-07-30 to 2023-08-06, AMGN's stock price increased from 227.62 to 234.28. News during this period are listed below:

No relative news reported.
From 2023-08-06 to 2023-08-13, AMGN's stock price increased from 234.28 to 252.80. News during this period are listed below:

No relative news reported.
From 2023-08-13 to 2023-08-20, AMGN's stock price increased from 252.80 to 254.17. News during this period are listed below:

No relative news reported.
[Basic Financials]:

No basic financial reported.

Based on all the information before 2023-08-20, let's first analyze the positive developments and potential concerns for AMGN. Come up with 2-4 most important factors respectively and keep them concise. Most factors should be inferred from company related news. Then let's assume your prediction for next week (2023-08-20 to 2023-08-27) is down by 2-3%. Provide a summary analysis to support your prediction. The prediction result need to be inferred from your analysis at the end, and thus not appearing as a foundational factor of your analysis.","[Positive Developments]:
1. The stock price of Amgen Inc has been consistently increasing over the past three weeks, which indicates a positive trend and investors' confidence in the company.
2. Since there has been no negative news reported during this period, it may suggest stability within the company's operations and predictability in its financial and business performance.

[Potential Concerns]:
1. The lack of any significant relative news might signify a stagnant period of innovation or progress within Amgen Inc. It could be a potential red flag for investors looking for active growth.
2. While not explicitly reported, the absence of basic financials may create uncertainty and concern among investors about its financial health and future.

[Prediction & Analysis]:
Considering the positive stock price trend over the past weeks, Amgen Inc seems to be a stable investment. However, the lack of news related to company growth or breakthroughs, along with the absence of financials, creates uncertainty. 

This imbalance can lead to a cautious outlook where investors might want to secure their gains from the recent price increase, leading to increased sell-offs. Thus, I predict that the price of AMGN might decrease by 2-3% in the upcoming week as investors take profits and wait for more company news or financials to assess their future investment decisions. The clear communication of business progress or the publishing of financials could alter this prediction, presenting an upside risk to our bearish outlook."
"[Company Introduction]:

Amgen Inc is a leading entity in the Biotechnology sector. Incorporated and publicly traded since 1983-06-17, the company has established its reputation as one of the key players in the market. As of today, Amgen Inc has a market capitalization of 180145.00 in USD, with 537.33 shares outstanding.

Amgen Inc operates primarily in the US, trading under the ticker AMGN on the NASDAQ NMS - GLOBAL MARKET. As a dominant force in the Biotechnology space, the company continues to innovate and drive progress within the industry.

From 2023-08-20 to 2023-08-27, AMGN's stock price decreased from 254.17 to 248.89. News during this period are listed below:

No relative news reported.
[Basic Financials]:

No basic financial reported.

Based on all the information before 2023-08-27, let's first analyze the positive developments and potential concerns for AMGN. Come up with 2-4 most important factors respectively and keep them concise. Most factors should be inferred from company related news. Then let's assume your prediction for next week (2023-08-27 to 2023-09-03) is up by 0-1%. Provide a summary analysis to support your prediction. The prediction result need to be inferred from your analysis at the end, and thus not appearing as a foundational factor of your analysis.","[Positive Developments]:
1. Amgen Inc continues to remain a dominant force in the Biotechnology sector, pointing towards stability and consistency.
2. Amgen Inc has maintained a positive reputation due to its constant innovation and driving progress within the industry, which contributes to investor confidence.

[Potential Concerns]:
1. The lack of related news over the past weeks presents a concern as investors cannot make informed decisions due to an absence of updated information.
2. The company's stock price has seen a decrease over the past week, which might indicate potential problems or lack of investor confidence.

[Prediction & Analysis]:

Given the absence of company-related news and fresh financial data, it's challenging to predict with certainty the near-term future of Amgen stock. However, given its historical stability and the company's general reputation in the Biotechnology sector, it's unlikely that this recent decline is indicative of a long-term trend. Therefore, I predict a minimal upward swing in the stock price, within a range of 0-1% for the week of 27th August to 3rd September 2023.

It's essential for investors and stock market analysts to monitor any upcoming company news and financial updates from Amgen as they might influence the stock's performance in the future."
"[Company Introduction]:

Amgen Inc is a leading entity in the Biotechnology sector. Incorporated and publicly traded since 1983-06-17, the company has established its reputation as one of the key players in the market. As of today, Amgen Inc has a market capitalization of 180145.00 in USD, with 537.33 shares outstanding.

Amgen Inc operates primarily in the US, trading under the ticker AMGN on the NASDAQ NMS - GLOBAL MARKET. As a dominant force in the Biotechnology space, the company continues to innovate and drive progress within the industry.

From 2023-08-13 to 2023-08-20, AMGN's stock price increased from 252.80 to 254.17. News during this period are listed below:

No relative news reported.
From 2023-08-20 to 2023-08-27, AMGN's stock price decreased from 254.17 to 248.89. News during this period are listed below:

No relative news reported.
From 2023-08-27 to 2023-09-03, AMGN's stock price increased from 248.89 to 249.21. News during this period are listed below:

No relative news reported.
[Basic Financials]:

No basic financial reported.

Based on all the information before 2023-09-03, let's first analyze the positive developments and potential concerns for AMGN. Come up with 2-4 most important factors respectively and keep them concise. Most factors should be inferred from company related news. Then let's assume your prediction for next week (2023-09-03 to 2023-09-10) is up by 1-2%. Provide a summary analysis to support your prediction. The prediction result need to be inferred from your analysis at the end, and thus not appearing as a foundational factor of your analysis.","[Positive Developments]:
1. Stable Stock Price: The stock price for Amgen Inc. has been generally stable in the past three weeks, showing a minor increasing trend which indicates investor confidence in the firm's potential.
2. Biotech Sector Growth: As a significant player in the biotechnology industry, Amgen can benefit from the overall growth in this sector. The biotech sector remains promising with ongoing research and development in the medical field.
  
[Potential Concerns]:
1. Lack of News: There has been no substantial news reported on the company in several weeks which can sometimes lead to uncertainties among investors.
2. Financial Data Absence: No basic financials were reported recently. This lack of transparency into the company's financial health can be a concern for potential investors.

[Prediction & Analysis]:

Despite the lack of major company news or reported financials in recent weeks, the overall stability in Amgen's stock price can be considered a positive indicator of its resilience and strong market presence. The company operates in the thriving biotechnology sector, which is poised for continuous growth due to constant innovations and high demand for healthcare solutions. This scenario primes Amgen to potentially accrue benefits from industry-wide advancements and trends.

Given these factors, in the upcoming week (from 2023-09-03 to 2023-09-10), it is anticipated that Amgen's stock price will experience a modest increase. This prediction is supported by its stable price history and the firm's advantageous position in a growth-oriented sector. However, it should be noted that the absence of company-specific news and transparent financials introduces an element of uncertainty in this prediction.
"
